What You Should Know
- The News: Wisp, the largest women’s telehealth company in the U.S., has acquired TBD Health, marking its first strategic acquisition and expanding its reach from Direct-to-Consumer (DTC) to enterprise and hybrid care. Financial details of the acquisition were not disclosed.
- The Gap: The deal targets a critical failure in public health: despite availability, only ~25% of eligible Americans are enrolled in PrEP (HIV prevention), with women being significantly underserved by current male-focused models.
- The Strategy: By integrating TBD Health’s national diagnostics infrastructure and hospital partnerships (Mount Sinai, Planned Parenthood), Wisp aims to provide a turnkey “TelePrEP” solution that bridges the gap between digital convenience and clinical rigor.
Largest Women’s Telehealth Provider Enters the Enterprise Market
For the past five years, the “Direct-to-Consumer” (DTC) telehealth wave has been defined by speed and convenience. Brands like Wisp dominated by offering discreet, efficient access to reproductive health and sexual wellness products delivered to the doorstep.
However, as we enter 2026, the ceiling for DTC is becoming visible. The next frontier isn’t just shipping medication; it is integrating with the healthcare system itself.
Today, Wisp signaled its aggressive entry into this new era by announcing the acquisition of TBD Health, a national sexual health platform with deep roots in enterprise and public health infrastructure. This marks Wisp’s first acquisition and a definitive strategic pivot from a pure-play consumer brand to a “hybrid care” powerhouse.
“This acquisition reflects where healthcare is going and where women have been left behind,” said Monica Cepak, CEO of Wisp. “TBD Health brings the infrastructure… that allow us to move into hybrid and enterprise care quickly.”
Closing the “TelePrEP” Gap
The acquisition is not just about business expansion; it is about addressing a glaring hole in the U.S. preventive care net.
While PrEP (Pre-Exposure Prophylaxis) has revolutionized HIV prevention, adoption is lagging dangerously. Only about 25% of the 2.4 million eligible Americans are enrolled in treatment. The statistics for women are even starker: despite accounting for 19% of new HIV diagnoses, women are frequently overlooked by prevention models designed historically for men.
Wisp is betting that TBD Health’s “TelePrEP” infrastructure is the key to unlocking this demographic. TBD operates a 50-state platform that combines routine STI/HIV diagnostics with virtual clinical support. By layering Wisp’s massive female user base (1.8 million patients) on top of this infrastructure, the combined entity aims to normalize and democratize HIV prevention for women.
The Enterprise Play: From Patient to Partner
For industry observers, the real story here is the “Enterprise” shift. TBD Health brings a rolodex of heavy-hitting partners that most DTC brands struggle to access, including Mount Sinai Health System, San Francisco AIDS Foundation, and Planned Parenthood Direct.
“Wisp is the only digital health company with the scale and trust to take our enterprise vision to the next level,” noted Stephanie Estey, Co-Founder of TBD Health.
This moves Wisp up the value chain. Instead of competing solely for individual credit card swipes, Wisp can now offer hospital systems and public health organizations a “turnkey solution” for sexual health. TBD’s platform integrates diagnostic testing directly into existing clinical workflows, ensuring that patients don’t fall through the cracks when moving between virtual and physical care settings.
